![]() |
Name |
1-Heptadecene
|
Molecular Formula | C17H34 | |
IUPAC Name* |
heptadec-1-ene
|
|
SMILES |
CCCCCCCCCCCCCCCC=C
|
|
InChI |
InChI=1S/C17H34/c1-3-5-7-9-11-13-15-17-16-14-12-10-8-6-4-2/h3H,1,4-17H2,2H3
|
|
InChIKey |
ADOBXTDBFNCOBN-UHFFFAOYSA-N
|
|
Synonyms |
1-HEPTADECENE; heptadec-1-ene; 6765-39-5; HEPTADECENE; Hexahydroaplotaxene; 26266-05-7; NSC 77132; 64743-02-8; NSC-77132; P33057D09T; heptadecen; UNII-P33057D09T; EINECS 229-825-6; EINECS 247-567-2; EINECS 265-207-2; MFCD00009000; C30-38 olefin; 1-Heptadecene, 98%; AI3-36483; UNII-04DAD0KDZ0; 04DAD0KDZ0; CHEBI:64502; DTXSID00873236; NSC77132; LMFA11000318; ZINC59201194; AKOS015912747; 1-heptadecene [standard material for gc]; DB-055053; FT-0607874; H0372; S0347; D90849; Q27104917
|
|
CAS | 6765-39-5 | |
PubChem CID | 23217 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 238.5 | ALogp: | 9.5 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 14 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 0.0 | Aromatic Rings: | 0 |
Heavy Atoms: | 17 | QED Weighted: | 0.236 |
Caco-2 Permeability: | -4.784 | MDCK Permeability: | 0.00001080 |
Pgp-inhibitor: | 0.003 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.205 |
30% Bioavailability (F30%): | 0.863 |
Blood-Brain-Barrier Penetration (BBB): | 0.201 | Plasma Protein Binding (PPB): | 100.09% |
Volume Distribution (VD): | 2.927 | Fu: | 1.17% |
CYP1A2-inhibitor: | 0.32 | CYP1A2-substrate: | 0.191 |
CYP2C19-inhibitor: | 0.411 | CYP2C19-substrate: | 0.068 |
CYP2C9-inhibitor: | 0.124 | CYP2C9-substrate: | 0.942 |
CYP2D6-inhibitor: | 0.337 | CYP2D6-substrate: | 0.241 |
CYP3A4-inhibitor: | 0.448 | CYP3A4-substrate: | 0.059 |
Clearance (CL): | 4.356 | Half-life (T1/2): | 0.068 |
hERG Blockers: | 0.143 | Human Hepatotoxicity (H-HT): | 0.008 |
Drug-inuced Liver Injury (DILI): | 0.05 | AMES Toxicity: | 0.011 |
Rat Oral Acute Toxicity: | 0.028 | Maximum Recommended Daily Dose: | 0.039 |
Skin Sensitization: | 0.966 | Carcinogencity: | 0.058 |
Eye Corrosion: | 0.995 | Eye Irritation: | 0.959 |
Respiratory Toxicity: | 0.306 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000283 | ![]() |
0.942 | D07ILQ | ![]() |
0.603 | ||
ENC000425 | ![]() |
0.939 | D0Z5SM | ![]() |
0.585 | ||
ENC000589 | ![]() |
0.891 | D00AOJ | ![]() |
0.547 | ||
ENC000573 | ![]() |
0.878 | D05ATI | ![]() |
0.500 | ||
ENC000475 | ![]() |
0.816 | D00FGR | ![]() |
0.494 | ||
ENC000715 | ![]() |
0.766 | D0O1PH | ![]() |
0.494 | ||
ENC000379 | ![]() |
0.759 | D0Z5BC | ![]() |
0.441 | ||
ENC000426 | ![]() |
0.759 | D0P1RL | ![]() |
0.364 | ||
ENC000510 | ![]() |
0.755 | D0T9TJ | ![]() |
0.349 | ||
ENC000082 | ![]() |
0.719 | D05QNO | ![]() |
0.347 |